Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
microRNA 5702 (MIR5702) is a small, non-coding RNA molecule found in the human genome. MicroRNAs, including MIR5702, are transcribed as primary transcripts and processed through well-defined enzymatic steps (Drosha, Dicer) to generate mature ~22 nucleotide RNAs that associate with Argonaute proteins in the RNA-induced silencing complex (RISC). They regulate gene expression by binding complementary sequences in target mRNAs—typically in the 3' untranslated region—leading to translational repression or mRNA degradation. The specific biological role, disease associations, and pharmacological relevance of MIR5702 remain poorly characterized in public databases and published literature as of September 2025. While some microRNAs act as oncogenes or tumor suppressors, no published data currently clarify MIR5702's direct involvement in cellular pathways, disease states, or its utility as a drug target.
No drugs are known to target MIR5702 specifically. General mechanisms of microRNAs: Bind to complementary sequences in mRNAs via the "seed" region (often at the 3' UTR), inhibiting translation or inducing mRNA degradation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on microRNA 5702 (MIR5702).